ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 7 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Trident Lifeline Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹47.1cr (+50% YoY), EBITDA ₹11.3cr (+65%), PAT ₹6.6cr (+30%). Capacity utilisation 46%. Parenterals facility pending commissioning.

Guidance and delivery
Management target Revenue 200.0%
Highlights
Revenue growthConsolidated +50%; standalone +19% YoY
MarginsConsolidated EBITDA 24.1% (+217bps YoY), down from 25.3% QoQ
Demand visibilityRegistrations filed 2,582 (+8%); global registrations 1,128 (+6%)
Management confidenceUpbeat: 'encouraging' quarter, tripling ambition reiterated

Growth

Consolidated EBITDA margin 24.1% (+217bps YoY). Standalone revenue ₹32.7cr (+19%). Medical devices +183%, tablets +11%, capsules -19%.

Outlook

Aspires to triple consolidated business in three years. Parenterals facility post-Diwali. Proposed preferential issue. 50,000 sq m land acquisition.

Risks

Capsules down 19%. Consolidated capacity utilisation only 46%. Finance cost up 95%. Consolidated PAT margin down 224bps to 14.0%.

Source

Investor Presentation filed with BSE, BSE: 543616. Summary written with AI assistance from the document.

Read the document ↗

Trident Lifeline Ltd: key numbers

Share price
₹413.75
Market cap
₹488.1 Cr
Revenue (annual)
₹129.0 Cr
Net profit (annual)
₹19.04 Cr
P/E (TTM)
25.6×Sector 43.0×
Promoter holding
62.54%-0.05% QoQ
FII holding
1.16%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Trident Lifeline Ltd

All →